ResMed's largely in-line third quarter results showcased a rising gross margin, while management also moved to ease market ...

Resmed says that U.S. Customs and Border Protection has confirmed that its devices will continue to be exempt from tariffs ...

Does the broker see value in this blue chip? Let's find out. The post What does Macquarie think ResMed shares are worth?

An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) is now available. ResMed Inc. has filed its ...

Morgans analyst Derek Jellinek maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – ...

Australian sleep health giant Resmed has locked down an exemption from Donald Trump’s sweeping trade tariffs. Resmed produces ...

Analysts have provided ResMed with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price ...

ResMed dominates healthcare devices with innovation, recurring revenues, and market leadership. See why we believe RMD stock ...

Resmed shares remained unmoved after hours today on third-quarter results that came in ahead of the consensus forecast.

Noise level: Our pick for the best quiet CPAP machine is the Luna G3, but you'll want to make sure that whichever model you ...

Resmed has named Salli Schwartz as chief investor relations officer, where she will lead the company’s global investor relations function and report to Mick Farrell, chairman of the board ...

KeyBanc analyst Brett Fishbin raised the firm’s price target on ResMed (RMD) to $274 from $269 on higher estimates, while keeping an Overweight ...